CTXR
Price
$1.77
Change
-$0.16 (-8.29%)
Updated
Jul 9 closing price
Capitalization
19.78M
IONS
Price
$42.83
Change
+$1.49 (+3.60%)
Updated
Jul 9 closing price
Capitalization
6.82B
21 days until earnings call
Interact to see
Advertisement

CTXR vs IONS

Header iconCTXR vs IONS Comparison
Open Charts CTXR vs IONSBanner chart's image
Citius Pharmaceuticals
Price$1.77
Change-$0.16 (-8.29%)
Volume$1.53M
Capitalization19.78M
Ionis Pharmaceuticals
Price$42.83
Change+$1.49 (+3.60%)
Volume$1.69M
Capitalization6.82B
CTXR vs IONS Comparison Chart in %
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. IONS commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Buy and IONS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (CTXR: $1.77 vs. IONS: $42.83)
Brand notoriety: CTXR and IONS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 45% vs. IONS: 99%
Market capitalization -- CTXR: $19.78M vs. IONS: $6.82B
CTXR [@Biotechnology] is valued at $19.78M. IONS’s [@Biotechnology] market capitalization is $6.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileIONS’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • IONS’s FA Score: 0 green, 5 red.
According to our system of comparison, CTXR is a better buy in the long-term than IONS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 5 TA indicator(s) are bullish while IONS’s TA Score has 4 bullish TA indicator(s).

  • CTXR’s TA Score: 5 bullish, 4 bearish.
  • IONS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CTXR is a better buy in the short-term than IONS.

Price Growth

CTXR (@Biotechnology) experienced а -15.71% price change this week, while IONS (@Biotechnology) price change was -1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.58%. For the same industry, the average monthly price growth was +16.60%, and the average quarterly price growth was +18.46%.

Reported Earning Dates

CTXR is expected to report earnings on May 14, 2025.

IONS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+12.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IONS($6.82B) has a higher market cap than CTXR($19.8M). IONS YTD gains are higher at: 22.511 vs. CTXR (-55.750). CTXR has higher annual earnings (EBITDA): -42.77M vs. IONS (-357.21M). IONS has more cash in the bank: 2.15B vs. CTXR (26.4K). CTXR has less debt than IONS: CTXR (932K) vs IONS (1.41B). IONS has higher revenues than CTXR: IONS (717M) vs CTXR (0).
CTXRIONSCTXR / IONS
Capitalization19.8M6.82B0%
EBITDA-42.77M-357.21M12%
Gain YTD-55.75022.511-248%
P/E RatioN/AN/A-
Revenue0717M-
Total Cash26.4K2.15B0%
Total Debt932K1.41B0%
FUNDAMENTALS RATINGS
CTXR vs IONS: Fundamental Ratings
CTXR
IONS
OUTLOOK RATING
1..100
3379
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3641
P/E GROWTH RATING
1..100
10069
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (9) in the Pharmaceuticals Major industry is significantly better than the same rating for IONS (96) in the Biotechnology industry. This means that CTXR’s stock grew significantly faster than IONS’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as IONS (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to IONS’s over the last 12 months.

CTXR's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as IONS (98) in the Biotechnology industry. This means that CTXR’s stock grew similarly to IONS’s over the last 12 months.

CTXR's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as IONS (41) in the Biotechnology industry. This means that CTXR’s stock grew similarly to IONS’s over the last 12 months.

IONS's P/E Growth Rating (69) in the Biotechnology industry is in the same range as CTXR (100) in the Pharmaceuticals Major industry. This means that IONS’s stock grew similarly to CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTXRIONS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 8 days ago
62%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPH34.151.56
+4.79%
Tri Pointe Homes
SYNX1.680.02
+1.20%
Silynxcom Ltd
HFFG3.280.02
+0.61%
HF Foods Group
IRS14.47-0.07
-0.48%
IRSA Inversiones Y Representaciones S.A
WIT3.07-0.02
-0.65%
Wipro Limited

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with HYPD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
-8.53%
HYPD - CTXR
37%
Loosely correlated
-6.66%
KLTO - CTXR
32%
Poorly correlated
+2.24%
ALEC - CTXR
31%
Poorly correlated
+8.55%
VERA - CTXR
28%
Poorly correlated
+5.26%
TAOX - CTXR
28%
Poorly correlated
-13.17%
More

IONS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IONS has been loosely correlated with ALNY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IONS jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IONS
1D Price
Change %
IONS100%
+3.60%
ALNY - IONS
54%
Loosely correlated
+1.06%
XENE - IONS
50%
Loosely correlated
+4.01%
RARE - IONS
50%
Loosely correlated
+5.12%
IDYA - IONS
50%
Loosely correlated
+7.09%
BEAM - IONS
49%
Loosely correlated
+5.71%
More